
John A. Jeffery
Examiner (ID: 13173)
| Most Active Art Unit | 3742 |
| Art Unit(s) | 2106, 3742 |
| Total Applications | 1303 |
| Issued Applications | 1052 |
| Pending Applications | 77 |
| Abandoned Applications | 174 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9383960
[patent_doc_number] => 20140087443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'OVER EXPRESSION OF FOLDASES AND CHAPERONES IMPROVES PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 14/011506
[patent_app_country] => US
[patent_app_date] => 2013-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9722
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/011506 | OVER EXPRESSION OF FOLDASES AND CHAPERONES IMPROVES PROTEIN PRODUCTION | Aug 26, 2013 | Abandoned |
Array
(
[id] => 9901504
[patent_doc_number] => 20150056704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'METHODS AND PRODUCTS FOR BIASING CELLULAR DEVELOPMENT'
[patent_app_type] => utility
[patent_app_number] => 13/969799
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12656
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13969799
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/969799 | Methods and products for biasing cellular development | Aug 18, 2013 | Issued |
Array
(
[id] => 9338888
[patent_doc_number] => 20140065670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'Expression System'
[patent_app_type] => utility
[patent_app_number] => 13/966600
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11390
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13966600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/966600 | Expression system | Aug 13, 2013 | Issued |
Array
(
[id] => 10129385
[patent_doc_number] => 09163211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => 'Animal protein free media for cultivation of cells'
[patent_app_type] => utility
[patent_app_number] => 13/960481
[patent_app_country] => US
[patent_app_date] => 2013-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8211
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960481
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/960481 | Animal protein free media for cultivation of cells | Aug 5, 2013 | Issued |
Array
(
[id] => 11548503
[patent_doc_number] => 09617335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-11
[patent_title] => 'Inducible coexpression system'
[patent_app_type] => utility
[patent_app_number] => 14/419653
[patent_app_country] => US
[patent_app_date] => 2013-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 36639
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419653
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419653 | Inducible coexpression system | Aug 4, 2013 | Issued |
Array
(
[id] => 9212085
[patent_doc_number] => 20140011262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Methods For Producing Secreted Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 13/945557
[patent_app_country] => US
[patent_app_date] => 2013-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19037
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945557
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/945557 | Methods For Producing Secreted Polypeptides | Jul 17, 2013 | Abandoned |
Array
(
[id] => 9449406
[patent_doc_number] => 20140120576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'NUCLEIC ACID WHICH IS STABILIZED AGAINST DECOMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/922393
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6467
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922393
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922393 | NUCLEIC ACID WHICH IS STABILIZED AGAINST DECOMPOSITION | Jun 19, 2013 | Abandoned |
Array
(
[id] => 11277290
[patent_doc_number] => 09493767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Method for screening for high L-tryptophan producing microorganisms using riboswitch'
[patent_app_type] => utility
[patent_app_number] => 14/406422
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4619
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406422
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406422 | Method for screening for high L-tryptophan producing microorganisms using riboswitch | Jun 18, 2013 | Issued |
Array
(
[id] => 9107678
[patent_doc_number] => 20130280810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'METHOD FOR THE SELECTION OF RECOMBINANT CLONES COMPRISING A SEQUENCE ENCODING AN ANTIDOTE PROTEIN TO TOXIC MOLECULE'
[patent_app_type] => utility
[patent_app_number] => 13/919952
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3617
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13919952
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/919952 | Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule | Jun 16, 2013 | Issued |
Array
(
[id] => 13856927
[patent_doc_number] => 10190175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Method for detecting and identifying enterohemorrhagic
[patent_app_type] => utility
[patent_app_number] => 14/407884
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12100
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407884
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/407884 | Method for detecting and identifying enterohemorrhagic | Jun 13, 2013 | Issued |
Array
(
[id] => 10340460
[patent_doc_number] => 20150225466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR PEPTIDE EXPRESSION AND PURIFICATION USING A TYPE III SECRETION SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/404919
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 25048
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404919 | Compositions and methods for peptide expression and purification using a type III secretion system | May 29, 2013 | Issued |
Array
(
[id] => 10290981
[patent_doc_number] => 20150175981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'SELECTION IN FUNGI'
[patent_app_type] => utility
[patent_app_number] => 14/403355
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11026
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403355
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403355 | Selection in fungi | May 28, 2013 | Issued |
Array
(
[id] => 14913661
[patent_doc_number] => 10428137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Protein assembler
[patent_app_type] => utility
[patent_app_number] => 14/404822
[patent_app_country] => US
[patent_app_date] => 2013-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22195
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 705
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404822
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404822 | Protein assembler | May 27, 2013 | Issued |
Array
(
[id] => 9198188
[patent_doc_number] => 20130337503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'MUTANT PROTEINASE WITH REDUCED SELF-CLEAVAGE ACTIVITY AND METHOD OF PURIFICATION'
[patent_app_type] => utility
[patent_app_number] => 13/898650
[patent_app_country] => US
[patent_app_date] => 2013-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15363
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13898650
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/898650 | Mutant proteinase with reduced self-cleavage activity and method of purification | May 20, 2013 | Issued |
Array
(
[id] => 9318363
[patent_doc_number] => 20140050701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'CAPSID-MODIFIED rAAV VECTOR COMPOSITIONS HAVING IMPROVED TRANSDUCTION EFFICIENCIES, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/899481
[patent_app_country] => US
[patent_app_date] => 2013-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 41589
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899481
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/899481 | Capsid-modified rAAV vector compositions having improved transduction efficiencies, and methods of use | May 20, 2013 | Issued |
Array
(
[id] => 12347586
[patent_doc_number] => 09951365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Recombinant bacterial host cell for protein expression
[patent_app_type] => utility
[patent_app_number] => 14/400068
[patent_app_country] => US
[patent_app_date] => 2013-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 20684
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400068
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400068 | Recombinant bacterial host cell for protein expression | May 12, 2013 | Issued |
Array
(
[id] => 11779345
[patent_doc_number] => 09388445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-12
[patent_title] => 'Enhancement of in vitro translation by nanoparticle conjugates'
[patent_app_type] => utility
[patent_app_number] => 13/868648
[patent_app_country] => US
[patent_app_date] => 2013-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7994
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13868648
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/868648 | Enhancement of in vitro translation by nanoparticle conjugates | Apr 22, 2013 | Issued |
Array
(
[id] => 8964239
[patent_doc_number] => 20130203841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'Transduction Efficiency, Capsid-Modified rAAV Vectors and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/855640
[patent_app_country] => US
[patent_app_date] => 2013-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27052
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855640
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/855640 | Transduction efficiency, capsid-modified rAAV vectors and methods of use | Apr 1, 2013 | Issued |
Array
(
[id] => 8989220
[patent_doc_number] => 20130216501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'THERAPEUTIC METHODS BASED ON TYROSINE-SUBSTITUTED, CAPSID-MODIFIED RAAV VECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/854011
[patent_app_country] => US
[patent_app_date] => 2013-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27123
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854011
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/854011 | Therapeutic methods based on tyrosine-substituted, capsid-modified rAAV vectors | Mar 28, 2013 | Issued |
Array
(
[id] => 10306734
[patent_doc_number] => 20150191735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'DNA PLASMIDS WITH IMPROVED EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/422865
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19372
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/422865 | DNA plasmids with improved expression | Mar 13, 2013 | Issued |